Company Filing History:
4 out of 9 
3 out of 6 
2 out of 5 
Years Active: 1998-2019
Title: Innovations and Contributions of Irene Erdelmeier
Introduction
Irene Erdelmeier is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of organoselenium compounds and their applications as antitumor agents. With a total of 11 patents to her name, her work has had a profound impact on medical research and treatment options.
Latest Patents
Among her latest patents, one focuses on organoselenium compounds, detailing a method for producing these compounds and their pharmaceutical uses, especially as antitumor agents. The invention describes a selenium compound with a specific formula, which can be utilized as a pharmaceutical substance. Another patent involves 5-acylsulfanyl-histidine compounds, which serve as precursors for the corresponding 5-sulfanylhistidines and their disulfides. This invention outlines the general formula for these compounds and their potential applications in producing various derivatives.
Career Highlights
Irene has worked with several companies throughout her career, including Oxis Isle of Man Limited and Tetrahedron. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Irene has collaborated with notable individuals in her field, including Marc E. Moutet and Jean-Claude Y. Yadan. These partnerships have further enhanced her research and development efforts, leading to significant advancements in her area of expertise.
Conclusion
Irene Erdelmeier's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a prominent figure in medical research. Her work continues to influence the development of new treatments and compounds that can benefit patients worldwide.